Lucy E. Flint
R&D, AstraZeneca
Cambridge, ENG CB20AA, United Kingdom
Cambridge, ENG CB20AA, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Automatic Tissue Detection for Mass Spectrometry Imaging.
Journal: Journal of the American Society for Mass Spectrometry
Published: November 25, 2025
Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 23, 2025
Camizestrant causes reversible pharmacological effects on retinal responses in rats.
Journal: Translational oncology
Published: April 03, 2025
Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response.
Journal: Metabolites
Published: April 18, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypes.
Journal: Nature communications
Published: October 03, 2023
Morphological and molecular preservation through universal preparation of fresh-frozen tissue samples for multimodal imaging workflows.
Journal: Nature protocols
Published: July 21, 2023
Multimodal Mass Spectrometry Imaging of an Aggregated 3D Cell Culture Model.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 06, 2023
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants.
Journal: Expert review of proteomics
Published: January 13, 2021
Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.
Journal: Pulmonary pharmacology & therapeutics
Published: December 14, 2017
A comparative study on the raft chemical properties of various alginate antacid raft-forming products.
Journal: Drug development and industrial pharmacy
Published: August 25, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026